{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"p5cs-deficiency","columns":[],"comparison":{"collapseColumnsLabel":"Show default populations","defaultColumnKeys":[],"expandColumnsLabel":"Show all source populations","intro":"Features recorded for this MONDO node. Related-node evidence is available through separately scoped comparisons.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column retains its native condition identifier, assessed population and annotation references. Counts are not pooled.</p>"},"coverage":{"countRecords":0,"emptyColumnKeys":[],"hpoRelease":"not available","narrativeSourceChanges":[],"records":0,"sourceGroups":{}},"features":[],"ledeHtml":"An inborn error of proline/orinthine metabolism that covers a wide spectrum of phenotypes and is caused by pathogenic variants in the aldehyde dehydrogenase 18 family member A1 (ALDH18A1) gene. These variants lead to a variety of neurocutaneous and motor syndromes characterized by cutis laxa, connective tissue weakness, facial dysmorphism, growth restriction, developmental delay, cataracts, hypotonia, hypertonia, and amyotrophy.","mondoId":"MONDO:0100126","node":{"canonicalSlug":"p5cs-deficiency","comparisons":[],"contexts":[],"lifecycle":"active","narrative":{"causes":[],"contentForm":"definition-only","matchMethod":"same-ontology-node","name":"P5CS deficiency","paragraphs":["An inborn error of proline/orinthine metabolism that covers a wide spectrum of phenotypes and is caused by pathogenic variants in the aldehyde dehydrogenase 18 family member A1 (ALDH18A1) gene. These variants lead to a variety of neurocutaneous and motor syndromes characterized by cutis laxa, connective tissue weakness, facial dysmorphism, growth restriction, developmental delay, cataracts, hypotonia, hypertonia, and amyotrophy."],"scope":"exact","source":"MONDO","upstream":"PMID:32017139","url":"https://monarchinitiative.org/MONDO:0100126"},"ownColumnKeys":[],"publication":"published","relationships":[{"kind":"parent","label":"inborn disorder of proline metabolism","mondoId":"MONDO:0017355","slug":"inborn-disorder-of-proline-metabolism"},{"kind":"parent","label":"inborn disorder of ornithine metabolism","mondoId":"MONDO:0017356","slug":"inborn-disorder-of-ornithine-metabolism"},{"kind":"child","label":"ALDH18A1-related de Barsy syndrome","mondoId":"MONDO:0009053","slug":"aldh18a1-related-de-barsy"},{"kind":"child","label":"autosomal recessive complex spastic paraplegia type 9B","mondoId":"MONDO:0014702","slug":"autosomal-recessive-complex-spastic-paraplegia-type-9b"},{"kind":"child","label":"cutis laxa, autosomal dominant 3","mondoId":"MONDO:0014706","slug":"cutis-laxa-autosomal-dominant-3"},{"kind":"child","label":"autosomal dominant spastic paraplegia type 9","mondoId":"MONDO:0015091","slug":"autosomal-dominant-spastic-paraplegia-type-9"}],"schemaVersion":1,"searchIndex":"/node-search/manifest.json","sourceHolds":{},"summaryHolds":[{"reason":"Public source record is not available in the frozen inputs","source":"GARD","url":"https://rarediseases.info.nih.gov/diseases/26056"}],"translation":"pending"},"records":[],"referenceLabels":{},"references":{"causeHtml":"<p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100126\" rel=\"noreferrer\">MONDO</a></p><details class=\"deep-dive\"><summary>Narrative source and scope</summary><dl><dt>Content</dt><dd>definition-only</dd><dt>Scope</dt><dd>exact</dd><dt>Match method</dt><dd>same-ontology-node</dd><dt>Upstream attribution</dt><dd>PMID:32017139</dd></dl></details>","identityNote":"MONDO identifies this node. Native source populations, annotation references and qualified comparison views retain their original scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>An inborn error of proline/orinthine metabolism that covers a wide spectrum of phenotypes and is caused by pathogenic variants in the aldehyde dehydrogenase 18 family member A1 (ALDH18A1) gene. These variants lead to a variety of neurocutaneous and motor syndromes characterized by cutis laxa, connective tissue weakness, facial dysmorphism, growth restriction, developmental delay, cataracts, hypotonia, hypertonia, and amyotrophy.</p><p class=\"section-source\">Source: <a href=\"https://monarchinitiative.org/MONDO:0100126\" rel=\"noreferrer\">MONDO</a></p>","key":"overview","title":"Brief description"}],"sharedSources":[],"slug":"p5cs-deficiency","sourceDocuments":[{"name":"MONDO: P5CS deficiency","reviewed":null,"source_release":"releases/2026-10-06","url":"https://monarchinitiative.org/MONDO:0100126"}],"sourceNote":"","synonyms":["delta1-pyrroline-5-carboxylate synthetase deficiency","P5CS deficiency"],"takeawayHtml":"","title":"P5CS deficiency"},"schemaVersion":1}
